Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation is a research paper published in Clinical Chemistry (2020). On theSindex it has a DataRank of 0. It has been cited 316 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01HL134320
Additional file 1 of Synergistic effect of the commonest residual risk factors, remnant cholesterol, lipoprotein(a), and inflammation, on prognosis of statin-treated patients with chronic coronary syndrome
Additional file 1 of Synergistic effect of the commonest residual risk factors, remnant cholesterol, lipoprotein(a), and inflammation, on prognosis of statin-treated patients with chronic coronary syndrome
Additional file 1 of Longitudinal association of remnant cholesterol with joint arteriosclerosis and atherosclerosis progression beyond LDL cholesterol
Additional file 1 of Longitudinal association of remnant cholesterol with joint arteriosclerosis and atherosclerosis progression beyond LDL cholesterol
Additional file 2 of Longitudinal association of remnant cholesterol with joint arteriosclerosis and atherosclerosis progression beyond LDL cholesterol
Additional file 2 of Longitudinal association of remnant cholesterol with joint arteriosclerosis and atherosclerosis progression beyond LDL cholesterol
Additional file 1 of Association of triglyceride-glucose index with myocardial injury post-stroke in older patients with first-ever ischemic stroke
Additional file 1 of Association of triglyceride-glucose index with myocardial injury post-stroke in older patients with first-ever ischemic stroke
Additional file 1 of Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease
Additional file 1 of Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease
Additional file 2 of Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease
Additional file 2 of Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease
Additional file 3 of Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease
Additional file 3 of Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease
Additional file 1 of Cumulative residual cholesterol predicts the risk of cardiovascular disease in the general population aged 45 years and older
Additional file 1 of Cumulative residual cholesterol predicts the risk of cardiovascular disease in the general population aged 45 years and older
Additional file 1 of High lipoprotein(a) concentration is associated with moyamoya disease
Additional file 1 of High lipoprotein(a) concentration is associated with moyamoya disease
Additional file 2 of High lipoprotein(a) concentration is associated with moyamoya disease
Additional file 2 of High lipoprotein(a) concentration is associated with moyamoya disease